Print

Rainbow BioSciences, LLC: Parkinson’s Costs Expected to Rise  
10/2/2012 10:07:00 AM

NOKOMIS, Fla.--(BUSINESS WIRE)--With cases of Parkinson’s disease sharply on the rise as the world’s population ages, the costs associated with the illness are rapidly rising, too. Rainbow Biosciences, the biotech subsidiary of Rainbow Coral Corp. (OTCBB: RBCC) is working on new solutions to help reduce the global costs associated with Parkinson’s and other neurological diseases.
//-->